Workflow
AptarGroup (ATR) Investor Presentation - Slideshow
AptarGroupAptarGroup(US:ATR)2022-09-09 16:11

Financial Performance & Capital Allocation - Aptar reported a 4% increase in sales and a 10% increase in core sales for the second quarter of 2022[23] - Aptar's capital expenditures for the first half of 2022 were approximately $150 million, primarily in the Pharma segment[20] - The company returned over $100 million to shareholders through dividends and share repurchases in the first half of 2022[20] - Year-to-date 2022 adjusted EPS was $2.00, compared to $2.50 in 2021, impacted by a higher effective tax rate[47] Segment Performance (Q2 2022) - Aptar Pharma achieved 12% core sales growth, driven by increased volumes across all end markets[57] - Aptar Beauty + Home achieved 10% core sales growth[61] - Aptar Food + Beverage achieved 8% core sales growth[66] Strategic Priorities & Sustainability - Aptar deployed over $3 billion since 2017, balanced across investing in the business, acquisitions, dividends, and share repurchases[20] - Aptar's 2021 Corporate Sustainability Report was released on June 22nd[13] - Aptar is targeting 4-7% sales growth and 20-22% EBITDA margin by 2025[72] - Aptar has over 5,000 active patents[7]